| Patents for A61P 31 - Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics (179,784) |
|---|
| 05/09/2007 | CN1958069A Triple high immunity immunoglobulin for anti swine pest, aujeszkys disease of pig, and parvovirus of pig |
| 05/09/2007 | CN1958068A Immunoglobulin of anti canine distemper in use for dogs, fox, and ermine |
| 05/09/2007 | CN1958065A Pidotimod capsule, and preparation |
| 05/09/2007 | CN1958060A Washing soap with effects of antiinflammation and bacteriostasis |
| 05/09/2007 | CN1958057A Application of extractive of Daliangjiang, and application in medication |
| 05/09/2007 | CN1958043A Method for preparing gel for wean to pacify common cold in children |
| 05/09/2007 | CN1957999A Composition of Chinese traditional medicine, preparation method, and quality control method |
| 05/09/2007 | CN1957985A Method for preparing gel of treating wind-heat type common cold |
| 05/09/2007 | CN1957983A Method for preparing gel of treating common cold in children |
| 05/09/2007 | CN1957961A Method for preparing extractive of purple daisy |
| 05/09/2007 | CN1957960A General flavone of Glabrous Herbcoral |
| 05/09/2007 | CN1957957A Application of Bijian grass in preparing medication for treating disease of tinea of hands, and tinea pedis, and preparation method for product |
| 05/09/2007 | CN1957952A Method for preparing wean quick acting gel for treating common cold |
| 05/09/2007 | CN1957951A Product for preventing and curing tuberculosis in assistance, and anti toxin and side effects of tuberculosis, and preparation method |
| 05/09/2007 | CN1957950A Product for enhancing physical performance, and preventing tuberculosis, and preparation method |
| 05/09/2007 | CN1957949A Method of medicament for curing skin disease |
| 05/09/2007 | CN1957947A Product for preventing and curing illeffect of antituberculosis drugs, and fabricating method |
| 05/09/2007 | CN1957945A Glycosyl hyperbranched suppressor in use for anti IIIV adhesion |
| 05/09/2007 | CN1957943A Injection of monoamine cysteine of glycyrrhizicacid and preparation |
| 05/09/2007 | CN1957938A Effervescence tablet of Glucurolactone, and preparation method |
| 05/09/2007 | CN1957924A Nano liposome of tea plant oil, and preparation method |
| 05/09/2007 | CN1314964C Finger print allas used for controlling isatidis root, its preparation quality and medicine effect and its making method |
| 05/09/2007 | CN1314706C Antigen epitope II of neutrality B cell of chicken IBDV VP2 protein and application thereof |
| 05/09/2007 | CN1314697C Anhydrous crystalline azido cytosine hemisulfate derivative |
| 05/09/2007 | CN1314692C Sodium ceftriaxone and its preparation method |
| 05/09/2007 | CN1314688C Pyridinebenzoxazine analog quinolone derivative and its preparation method and uses |
| 05/09/2007 | CN1314683C Indole derivatives or benzimidazole derivatives for modulating IKB kinase |
| 05/09/2007 | CN1314674C Use of 2-amino-thiazoline derivatives as inhibitors of inducible NO-synthase |
| 05/09/2007 | CN1314450C Multicomponent vaccines |
| 05/09/2007 | CN1314449C Combined vaccine composed of viral of Japanese b encephalitis and vaccine of brain fever cocci |
| 05/09/2007 | CN1314444C Medicinal composition for treating diabetes and its complication and viral hepatitis and its preparation method |
| 05/09/2007 | CN1314421C Cordate houttuynia mixture for preventing and treating livestock bird infectious disease |
| 05/09/2007 | CN1314413C Chinese medicine treating AIDS and its prepn. |
| 05/09/2007 | CN1314410C Chinese medicinal formulation for health-care and heptitis treatment |
| 05/09/2007 | CN1314399C Child metho kahuangmin effervescent granules and its making method |
| 05/09/2007 | CN1314398C Cream for treating dexmatosis, and its prepn. method |
| 05/09/2007 | CN1314396C Application of levoornidazole in preparation of anti anaerobic bacteria infection medicine |
| 05/08/2007 | US7214798 E.g., 2-(Methylamino)-2-oxoethyl 3-[1-(1-isoquinolyl)-4-piperidyl]propylcarbamate hydrochloride and 3{2-[1-(2-quinolyl)-4-piperidyl]-ethyl}-1,3-oxazolidine-2,4-dione; analgesics |
| 05/08/2007 | US7214710 Permeable, water soluble, non-irritating prodrugs of chemotherapeutic agents with oxaalkanoic acids |
| 05/08/2007 | US7214707 Dimeric compounds and their use as anti-viral agents |
| 05/08/2007 | US7214705 Antiproliferative activity and is most unlikely a substrate for P-glycoprotein and/or Multidrug Resistant Protein |
| 05/08/2007 | US7214679 treatment of inflammation, proliferative diseases, and certain cardiovascular disorders as well as Alzheimer's disease; |
| 05/08/2007 | US7214677 Benzamide, heteroarylamide and reverse amides |
| 05/08/2007 | US7214676 Spirotricyclic derivatives and their use as phosphodiesterase-7 inhibitors |
| 05/08/2007 | US7214675 Administering the compound N-{2-[2-(4-amino-2-ethyl-1H-imidazo[4,5-c]quinolin-1-yl)ethoxy]ethyl}morpholine-4-carboxamide inducing cytokine biosynthesis; Viricides; anticancer agents; immunology moderators |
| 05/08/2007 | US7214669 Tetracycline derivatives and methods of use thereof |
| 05/08/2007 | US7214668 Viricides; anticancer agents; liver disorders |
| 05/08/2007 | US7214663 The prodrug of the invention is a modified form of a therapeutic agent and comprises a therapeutic agent, an oligopeptide of three amino acids, a stabilizing group and, optionally, a linker group. The prodrug is cleavable by a |
| 05/08/2007 | US7214506 Method for treating onychomycosis |
| 05/08/2007 | US7214499 Contacting the sample with an isolated antibody specific for an EspA polypeptide, wherein the polypeptide is a secreted protein from enteropathogenic E. coli, detecting binding of the antibody to EspA polypeptide |
| 05/08/2007 | CA2306837C Treatment of female sexual dysfunction |
| 05/08/2007 | CA2302833C Peptides derived from the attachment (g) protein of respiratory syncytial virus |
| 05/08/2007 | CA2293612C Regulation of transcription in mammalian cells and viral replication by a tetracyclin repressor |
| 05/08/2007 | CA2290421C Multicyclic erythromycin derivatives |
| 05/08/2007 | CA2273824C Mutants of streptococcal toxin c and methods of use |
| 05/08/2007 | CA2253338C 6-o-substituted erythromycins and method for making them |
| 05/08/2007 | CA2207120C Use of theophylline derivatives for the treatment and prophylaxis of states of shock, novel xanthine compounds and processes for their preparation |
| 05/08/2007 | CA2185489C Cyclic adhesion inhibitors |
| 05/08/2007 | CA2137912C Combinatorial polypeptide antigens |
| 05/08/2007 | CA2118564C Erythromycin derivatives, process for the preparation thereof and use thereof as medicaments |
| 05/08/2007 | CA2102918C Genetic vaccine for immunodeficiency viruses |
| 05/03/2007 | WO2007050375A2 Piperazine derivatives useful as ccr5 antagonists |
| 05/03/2007 | WO2007049803A1 New cyclic peptide compounds |
| 05/03/2007 | WO2007049771A1 Compound containing basic group and use thereof |
| 05/03/2007 | WO2007049770A1 Outer coat protein pa5158 of pseudomonas aeruginosa |
| 05/03/2007 | WO2007049675A1 Polycyclic carbamoylpyridone derivative having inhibitory activity on hiv integrase |
| 05/03/2007 | WO2007049582A1 Thiopeptide compound |
| 05/03/2007 | WO2007049394A1 Peptides originating in hepatitis c virus |
| 05/03/2007 | WO2007048848A2 V-atpase inhibitors for use in the treatment of septic shock |
| 05/03/2007 | WO2007048820A2 Micronised azodicarbonamide, the preparation and use thereof |
| 05/03/2007 | WO2007048311A1 Pharmaceutical composition having a ruthenium oxalato compound and method of using the same |
| 05/03/2007 | WO2007023072A3 Use of ambroxol for the treatment of rhinovirus infections |
| 05/03/2007 | WO2007011396A3 Particles for treatment of pulmonary infection |
| 05/03/2007 | WO2007009120A3 Heterotetracyclic compounds as tpo mimetics |
| 05/03/2007 | WO2007008673A3 Crystalline anhydrous cefdinir and crystalline cefdinir hydrates |
| 05/03/2007 | WO2006122011A3 Thiazole compounds and methods of use |
| 05/03/2007 | WO2006109192A8 Antifungal bifunctional molecules, methods of construction and methods of treating fungal infection therewith |
| 05/03/2007 | WO2006073496A3 Recombinant aav based vaccine methods |
| 05/03/2007 | WO2006024770A8 Phosphole derivatives complexed with metals, and pharmaceutical uses thereof |
| 05/03/2007 | WO2005092069A8 Chimeric infectious dna clones, chimeric porcine circoviruses and uses thereof |
| 05/03/2007 | US20070099991 Selective rxr ligands |
| 05/03/2007 | US20070099985 Heteroaromate OSC inhibitors |
| 05/03/2007 | US20070099932 External preparation for athlete's foot treatment |
| 05/03/2007 | US20070099921 Heteroaryl, heterocyclic and aryl compounds which inhibit leukocyte adhesion mediated by VLA-4 |
| 05/03/2007 | US20070099899 Heterocyclic dihydropyrimidine compounds |
| 05/03/2007 | US20070099870 Lipid analogs for combating tumors |
| 05/03/2007 | US20070099855 Glycyrrhizin or derivatives thereof for for treating or preventing severe acute respiratory syndrome (sars) |
| 05/03/2007 | US20070099181 isolation and characterization of new porcine circovirus (PCV) isolates from pigs displaying postweaning multisystemic wasting syndrome (PMWS). |
| 05/03/2007 | US20070098747 Topical pharmaceutical composition for the treatment of inflammatory dermatoses |
| 05/03/2007 | US20070098741 Vectors derived from antibodies for transferring substances into cells |
| 05/03/2007 | US20070098739 Vaccine compositions for vaccinating dogs against canine infectious respiratory disease |
| 05/03/2007 | US20070098737 Streptococcal streptolysin S vaccines |
| 05/03/2007 | US20070098688 Polymer conjugates of interferon beta-1a and uses |
| 05/03/2007 | US20070098687 Pharmaceutical composition containing interferon for the treatment of hpv infections |
| 05/03/2007 | CA2627608A1 Micronised azodicarbonamide, the preparation and use thereof |
| 05/03/2007 | CA2627309A1 Pseudomonas aeruginosa outer membrane protein pa5158 |
| 05/03/2007 | CA2627302A1 Compositions comprising yersinia pestis antigens |
| 05/03/2007 | CA2627000A1 Small interfering ribonucleic acid duplexes comprising arabinose modified nucleotides |
| 05/03/2007 | CA2626976A1 Heterocyclic aspartyl protease inhibitors |
| 05/03/2007 | CA2626956A1 Polycyclic carbamoylpyridone derivative having hiv integrase inhibitory activity |